NYSE$COR
Cencora Inc · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
AmerisourceBergen reported strong financial results for Q2 2023, with revenue increasing by 9.9% year-over-year and adjusted diluted EPS rising by 8.7%.
AmerisourceBergen Corporation's Q2 2023 earnings showcased a robust 9.9% increase in revenue, reaching $63.5 billion. Adjusted diluted EPS grew by 8.7% to $3.50, reflecting the company's strong financial performance and strategic execution. The company raised its full-year financial outlook, demonstrating the value of its pharmaceutical-centric strategy and key strategic partnerships.
- Revenue increased by 9.9% year-over-year to $63.5 billion.
- GAAP diluted EPS was $2.13, while adjusted diluted EPS increased by 8.7% to $3.50.
- U.S. Healthcare Solutions revenue increased by 11.3% year-over-year.
- The company raised its adjusted diluted EPS guidance range for fiscal year 2023 to $11.70 to $11.90.
Headline financials
Revenue & EPS history
Cencora · Revenue · Quarterly
$63.5B
Forward guidance
AmerisourceBergen is updating its fiscal year 2023 financial guidance to primarily reflect stronger core growth in the U.S. Healthcare Solutions segment. The Company now expects revenue growth to be in the range of 6 to 8 percent and Adjusted Diluted Earnings Per Share to be in the range of $11.70 to $11.90.
Tailwinds
- Revenue growth to be in the range of 6 to 8 percent, up from the previous range of 5 to 7 percent.
- U.S. Healthcare Solutions revenue growth to be in the range of 7 to 8 percent, narrowed from the previous range of 6 to 8 percent.
- International Healthcare Solutions revenue to be in the range of a 3 percent decline to flat, up from the previous range of a 1 to 5 percent decline.
- Adjusted Diluted Earnings Per Share to be in the range of $11.70 to $11.90, representing growth of 6 to 8 percent, raised from the previous range of $11.50 to $11.75.
- Adjusted consolidated operating income growth to be in the range of 2 to 4 percent, up from the previous range of 0 to 3 percent.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2023
-0.1%
Avg return
Earnings day
+0.3%
Avg return
5 days after
+1.4%
Avg return
30 days after
48%
35 / 73 earnings
Positive
+7.8%
Q2 2019
Best reaction
-18.4%
Q2 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | -18.4% | -16.6% | -10.1% | |
| Q1 2026 | -5.9% | +0.4% | -0.9% | |
| Q4 2025 | +2.9% | +5.8% | -1.4% | |
| Q3 2025 | -2.9% | -0.6% | +0.1% | |
| Q2 2025 | +4.6% | -4.3% | -0.6% | |
| Q1 2025 | +0.7% | -2.1% | +1.2% | |
| Q4 2024 | +5.9% | +6.5% | +4.0% | |
| Q3 2024 | +5.8% | +4.4% | +3.7% | |
| Q2 2024 | -6.0% | -6.3% | -5.2% | |
| Q1 2024 | +7.4% | +6.2% | +7.5% | |
| Q4 2023 | +4.2% | +4.7% | +9.0% | |
| Q3 2023 | +1.2% | -1.3% | -7.5% | |
| Q2 2023 | +0.1% | +0.7% | +3.5% | |
| Q1 2023 | -6.2% | -8.6% | -7.6% | |
| Q4 2022 | +4.4% | +3.1% | +12.4% | |
| Q3 2022 | -2.5% | -1.5% | +3.4% | |
| Q2 2022 | +2.9% | +4.4% | -2.5% | |
| Q1 2022 | +0.2% | +1.3% | +7.0% | |
| Q4 2021 | -0.6% | -2.8% | -9.0% | |
| Q3 2021 | -1.5% | -2.8% | +1.2% | |
| Q2 2021 | -6.5% | -2.1% | -7.1% | |
| Q1 2021 | +3.9% | +1.8% | -0.7% | |
| Q4 2020 | -1.0% | +4.8% | -1.9% | |
| Q3 2020 | -3.0% | -1.6% | -7.7% | |
| Q2 2020 | +3.0% | +3.6% | +15.8% | |
| Q1 2020 | -4.8% | -2.0% | -6.2% | |
| Q4 2019 | +1.6% | +1.0% | +4.2% | |
| Q3 2019 | +3.8% | -3.5% | -5.6% | |
| Q2 2019 | +7.8% | +5.5% | +6.1% | |
| Q1 2019 | +6.7% | +9.2% | +5.7% | |
| Q4 2018 | -2.3% | +0.3% | -2.9% | |
| Q3 2018 | +1.9% | +5.0% | +13.2% | |
| Q2 2018 | -4.3% | -5.1% | -6.6% | |
| Q1 2018 | +2.5% | -2.9% | +4.7% | |
| Q4 2017 | -2.4% | -2.2% | +10.9% | |
| Q3 2017 | -11.4% | -12.0% | -12.1% | |
| Q2 2017 | +3.9% | +5.9% | +13.2% | |
| Q1 2017 | +6.0% | +6.8% | +9.9% | |
| Q4 2016 | +3.6% | +3.1% | +12.9% | |
| Q3 2016 | +5.1% | +4.5% | +1.9% | |
| Q2 2016 | -9.2% | — | — | |
| Q1 2016 | -3.7% | — | — | |
| Q4 2015 | -1.0% | — | — | |
| Q3 2015 | -5.4% | — | — | |
| Q2 2015 | +1.9% | — | — | |
| Q1 2015 | +0.4% | — | — | |
| Q4 2014 | +7.1% | — | — | |
| Q3 2014 | +3.7% | — | — | |
| Q2 2014 | -3.1% | — | — | |
| Q1 2014 | -4.3% | — | — | |
| Q4 2013 | +1.8% | — | — | |
| Q3 2013 | -0.0% | — | — | |
| Q2 2013 | -4.6% | — | — | |
| Q1 2013 | -5.1% | — | — | |
| Q4 2012 | -0.6% | — | — | |
| Q3 2012 | +2.7% | — | — | |
| Q2 2012 | -1.2% | — | — | |
| Q1 2012 | +2.4% | — | — | |
| Q4 2011 | -1.0% | — | — | |
| Q3 2011 | -0.5% | — | — | |
| Q2 2011 | +2.9% | — | — | |
| Q1 2011 | +0.5% | — | — | |
| Q4 2010 | -0.5% | — | — | |
| Q3 2010 | -0.7% | — | — | |
| Q2 2010 | +1.0% | — | — | |
| Q1 2009 | -1.7% | — | — | |
| Q1 2010 | +1.2% | — | — | |
| Q4 2009 | -0.6% | — | — | |
| Q2 2009 | -0.6% | — | — | |
| Q4 2007 | -0.6% | — | — | |
| Q3 2008 | -0.5% | — | — | |
| Q3 2009 | -0.5% | — | — | |
| Q4 2008 | -0.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro